Dr. Nicole E. Skinner, MD

Dr. Skinner practices at Ohio State University Hospital in Columbus, Ohio, part of The Ohio State University Wexner Medical Center.

Dr. Skinner's NPI, 1487035564, was assigned on June 14, 2015. Dr. Skinner graduated from University of Minnesota Medical School in 2015. Dr. Skinner holds Ohio license 35.143959.

Dr. Skinner's primary practice is Ohio State University Hospital, at 410 West 10th Avenue, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-9700.

Dr. Skinner's primary practice is Ohio State University Hospital in Columbus, Ohio, part of The Ohio State University Wexner Medical Center. Dr. Skinner is also affiliated with The James Cancer Hospital and Solove Research Institute. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Skinner to 2 more hospital outpatient departments and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skinner practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Skinner's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Skinner's licenses on file in 2 states: Ohio and Maryland.

CMS data shows 43 Medicare services from Dr. Skinner across 2 procedure codes in 2024, for 45 Medicare patients. Medicare paid $3,938 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 45 Medicare patients who saw Dr. Skinner in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Skinner's median patient age at 54, with 39% women.

In 2024, Dr. Skinner wrote 20 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $2,770 in total drug cost. In 2021, CMS named 14 claims across 1 drug.

Dr. Skinner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Skinner, published from 2019 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Hepatitis C, Hepacivirus and Antibodies, Neutralizing. Dr. Skinner has published most often in Front Immunol. Dr. Skinner's most frequent co-authors are James Crowe, MD, Paul W. Blair, MD and Paul M. Hassoun, MD.

Dr. Skinner graduated from University of Minnesota Medical School in 2015.